Recursion Pharmaceuticals Inc
RXRX4.660USD
-0.040-0.85%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
2.29BMarket Cap
LossP/E TTM
Recursion Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
58.84M
32.00%
EPS(YoY)
-1.69
-7.13%
Analyst Rating
HOLD
2026-01-07
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 58.84M, with a year-on-year change of 32.00%.
What is the Earnings Per Share (EPS) of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -1.691, with a year-on-year change of -7.13%.
What is the net income of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its net income was -463.66M, with a year-on-year change of -41.33%.
What is the net margin of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was -788.02%, with a year-on-year change of -7.07%.
What is the gross margin of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 23.12%, with a year-on-year change of 418.30%.
What is the debt-to-asset ratio of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 1.89%, with a year-on-year change of 984.56%.
What is the Return on Equity (ROE) of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -61.89%, with a year-on-year change of 10.46%.
What is the Return on Assets (ROA) of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -44.11%, with a year-on-year change of 8.91%.
What is the operating profit of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -479.00M, with a year-on-year change of -37.31%.
What are the current assets of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its current assets were 714.27M, with a year-on-year change of 63.02%.
What are the total assets of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its total assets of Recursion Pharmaceuticals Inc were 1.45B, with a year-on-year change of 121.60%.
What are the total liabilities of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Recursion Pharmaceuticals Inc were 413.82M, with a year-on-year change of 117.50%.
What is the total equity of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its total equity of Recursion Pharmaceuticals Inc was 1.03B, with a year-on-year change of 123.28%.
What is the net operating income of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Recursion Pharmaceuticals Inc was -463.66M, with a year-on-year change of -41.33%.
What is the net investment of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its net investment of Recursion Pharmaceuticals Inc was 260.06M, with a year-on-year change of 2642.62%.
What is the net financing of Recursion Pharmaceuticals Inc?
According to Recursion Pharmaceuticals Inc's FY2024 earnings report, its net financing of Recursion Pharmaceuticals Inc was 304.12M, with a year-on-year change of 117.02%.
